Mdd Us Drug Patent Portfolio
Mdd Us owns 1 orange book drug protected by 3 US patents Given below is the list of Mdd Us's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8283380 | Methods for treatment of parkinson's disease | 21 Mar, 2031 | Active |
| US8076515 | Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides | 10 Dec, 2028 | Active |
| US8278485 | Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides | 08 Jun, 2027 | Active |
Latest Legal Activities on Mdd Us's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mdd Us.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 09 Apr, 2024 | US8283380 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Apr, 2024 | US8278485 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Jun, 2023 | US8076515 |
|
Patent Term Extension Certificate
Critical
| 21 May, 2021 | US8283380 |
|
Withdrawal of Application for PTE
Critical
| 20 May, 2021 | US8076515 |
| Election in Response to Notice of Final Determination | 16 Mar, 2021 | US8283380 |
| Notice of Final Determination -Election Required | 09 Mar, 2021 | US8283380 |
| Notice of Final Determination -Election Required | 09 Mar, 2021 | US8076515 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 09 Apr, 2020 | US8283380 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Apr, 2020 | US8278485 |
|
FDA Final Eligibility Letter
Critical
| 16 Sep, 2019 | US8283380 |
|
FDA Final Eligibility Letter
Critical
| 16 Sep, 2019 | US8076515 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Jun, 2019 | US8076515 |
| transaction for FDA Determination of Regulatory Review Period | 12 Feb, 2019 | US8076515 |
| transaction for FDA Determination of Regulatory Review Period | 11 Feb, 2019 | US8283380 |
Mdd Us's Family Patents
Mdd Us Drug List
Given below is the complete list of Mdd Us's drugs and the patents protecting them.
1. Xadago
Xadago is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8283380 | Methods for treatment of parkinson's disease |
21 Mar, 2031
(5 years from now)
| Active |
| US8076515 | Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides |
10 Dec, 2028
(2 years from now)
| Active |
| US8278485 | Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides |
08 Jun, 2027
(1 year, 5 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xadago's drug page